| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Spectrum Pharmaceuticals Inc (F: NTR)
NTR Technical Analysis
3
| As on 2nd Aug 2023 NTR STOCK Price closed @ 0.92 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.73 & Buy for SHORT-TERM with Stoploss of 0.88 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NTRSTOCK Price
| Open | 0.92 | Change | Price | % |
| High | 0.92 | 1 Day | 0.00 | 0.00 |
| Low | 0.92 | 1 Week | 0.00 | 0.00 |
| Close | 0.92 | 1 Month | -0.05 | -5.15 |
| Volume | N/A | 1 Year | 0.33 | 55.93 |
| 52 Week High 1.48 | 52 Week Low 0.26 | ||||
F Germany Most Active Stocks
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| TEF | 3.84 | -0.52% |
| TEF | 3.84 | -0.52% |
| WHL | 5150.00 | -0.44% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
F Germany Top Gainers Stocks
F Germany Top Losers Stocks
| NTR Daily Charts |
NTR Intraday Charts |
Whats New @ Bazaartrend |
NTR Free Analysis |
|
|
NTR Important Levels Intraday
| RESISTANCE | 0.92 |
| RESISTANCE | 0.92 |
| RESISTANCE | 0.92 |
| RESISTANCE | 0.92 |
| RESISTANCE | 0.92 |
| RESISTANCE | 0.92 |
| RESISTANCE | 0.92 |
| RESISTANCE | 0.92 |
NTR Forecast February 2026
| 4th UP Forecast | 2.08 |
| 3rd UP Forecast | 1.71 |
| 2nd UP Forecast | 1.48 |
| 1st UP Forecast | 1.25 |
| 1st DOWN Forecast | 0.59 |
| 2nd DOWN Forecast | 0.36 |
| 3rd DOWN Forecast | 0.13 |
| 4th DOWN Forecast | -0.24 |
NTR Weekly Forecast
| 4th UP Forecast | 1.13 |
| 3rd UP Forecast | 1.06 |
| 2nd UP Forecast | 1.02 |
| 1st UP Forecast | 0.98 |
| 1st DOWN Forecast | 0.86 |
| 2nd DOWN Forecast | 0.82 |
| 3rd DOWN Forecast | 0.78 |
| 4th DOWN Forecast | 0.71 |
NTR Forecast2026
| 4th UP Forecast | 3.41 |
| 3rd UP Forecast | 2.61 |
| 2nd UP Forecast | 2.12 |
| 1st UP Forecast | 1.62 |
| 1st DOWN Forecast | 0.22 |
| 2nd DOWN Forecast | -0.28 |
| 3rd DOWN Forecast | -0.77 |
| 4th DOWN Forecast | -1.57 |
Spectrum Pharmaceuticals Inc ( F Germany Symbol : NTR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NTR Business Profile
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include ROLONTIS, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations; and Anti-CD20-IFNa, an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for the treatment of patients with relapsed or refractory non-Hodgkin's lymphoma, including diffuse large B-cell lymphoma. It has co-development, commercialization, and in-license agreements with Hanmi Pharmaceutical Co. Ltd.; a patent and technology license agreement with The University of Texas M.D. Anderson Cancer Center; and in-license agreement with ImmunGene, Inc. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Henderson, Nevada. Address: 11500 South Eastern Avenue, Henderson, NV, United States, 89052
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service